Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Vaccine/Immunotherapy

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: A substudy of two randomised controlled trials (COV001 and COV002)

The Lancet | Sep 06, 2021 Vaccine/Immunotherapy

Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines

Journal of the European Academy of Dermatology and Venereology | Sep 05, 2021 Vaccine/Immunotherapy

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: An interim analysis of a randomized, double-blind, placebo-controlled, phase 1B/2A trial

The Lancet HIV | Sep 05, 2021 Vaccine/Immunotherapy

Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273

JAMA | Sep 03, 2021 Vaccine/Immunotherapy

Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016–2017 through 2019–2020 influenza seasons

PLoS Neglected Tropical Diseases | Sep 02, 2021 Vaccine/Immunotherapy

Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting

New England Journal of Medicine | Aug 30, 2021 Vaccine/Immunotherapy

Seasonal malaria vaccination with or without seasonal malaria chemoprevention

New England Journal of Medicine | Aug 30, 2021 Vaccine/Immunotherapy

Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer

JAMA | Aug 25, 2021 Vaccine/Immunotherapy

Seropositivity following mRNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer

JAMA | Aug 25, 2021 Vaccine/Immunotherapy

Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity

JAMA | Aug 25, 2021 Vaccine/Immunotherapy

« Prev 1 … 5 6 7 8 9 … 42 Next »

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: A substudy of two randomised controlled trials (COV001 and COV002)

Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: An interim analysis of a randomized, double-blind, placebo-controlled, phase 1B/2A trial

Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273

Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016–2017 through 2019–2020 influenza seasons

Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting

Seasonal malaria vaccination with or without seasonal malaria chemoprevention

Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer

Seropositivity following mRNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer

Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: A substudy of two randomised controlled trials (COV001 and COV002)

Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: An interim analysis of a randomized, double-blind, placebo-controlled, phase 1B/2A trial

Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273

Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016–2017 through 2019–2020 influenza seasons

Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting

Seasonal malaria vaccination with or without seasonal malaria chemoprevention

Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer

Seropositivity following mRNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer

Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic